{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:08:40Z","timestamp":1788390520766,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003511"],"award-info":[{"award-number":["82003511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Discipline and Platform Construction Project of Center for AIDS Research, Wuhan University","award":["PTPP2023002"],"award-info":[{"award-number":["PTPP2023002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99072-y","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:18:32Z","timestamp":1746595112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma proteomic analysis reveals altered protein abundances in HIV\/HBV co-infection individuals with HCC and with liver cirrhosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yongxi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xien","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"5","key":"99072_CR1","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/hep.32792","volume":"77","author":"X Mao","year":"2023","unstructured":"Mao, X. et al. HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis. Hepatology 77 (5), 1735\u20131745 (2023). Steatosis.","journal-title":"Hepatology"},{"issue":"1","key":"99072_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Hepatitis B infection in the general population of China: A systematic review and meta-analysis. BMC Infect. Dis. 19 (1), 811 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"99072_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/jvh.13212","volume":"27","author":"R Yang","year":"2020","unstructured":"Yang, R. et al. Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV\/HBV co\u2010infected Chinese. J. Viral Hepat. 27 (2), 127\u2013134 (2020).","journal-title":"J. Viral Hepat."},{"issue":"11","key":"99072_CR4","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/cid\/ciz1170","volume":"71","author":"S Leumi","year":"2020","unstructured":"Leumi, S. et al. Global burden of hepatitis B infection in people living with human immunodeficiency virus: A systematic review and Meta-analysis. Clin. Infect. Dis. 71 (11), 2799\u20132806 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"99072_CR5","doi-asserted-by":"crossref","unstructured":"Robbins, H. A. et al. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS ;28(6):881\u2013890. (2014).","DOI":"10.1097\/QAD.0000000000000163"},{"issue":"1","key":"99072_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jviscsurg.2010.02.003","volume":"147","author":"MP Vullierme","year":"2010","unstructured":"Vullierme, M. P. et al. Hepatocellular carcinoma\u2014what\u2019s new? J. Visc. Surg. 147 (1), e1\u201312 (2010).","journal-title":"J. Visc. Surg."},{"issue":"4","key":"99072_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/hepr.12739","volume":"47","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma. Hepatol. Res. 47 (4), 312\u2013320 (2017).","journal-title":"Hepatol. Res."},{"issue":"2","key":"99072_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","volume":"26","author":"P Luo","year":"2020","unstructured":"Luo, P. et al. Current status and perspective biomarkers in AFP negative HCC: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol. Oncol. Res. 26 (2), 599\u2013603 (2020).","journal-title":"Pathol. Oncol. Res."},{"issue":"3","key":"99072_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix, J. & Sherman, M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology 53 (3), 1020\u20131022 (2011).","journal-title":"Hepatology"},{"key":"99072_CR10","doi-asserted-by":"publisher","first-page":"100302","DOI":"10.1016\/j.mtbio.2022.100302","volume":"15","author":"Z Xun","year":"2022","unstructured":"Xun, Z. et al. Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach. Mater. Today Bio. 15, 100302 (2022).","journal-title":"Mater. Today Bio"},{"issue":"2","key":"99072_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-Related hepatocellular carcinoma. Cell 179 (2), 561\u2013577e22 (2019).","journal-title":"Cell"},{"issue":"9","key":"99072_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer, P. E. et al. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13 (9), 942 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"99072_CR13","doi-asserted-by":"publisher","first-page":"30853","DOI":"10.1038\/srep30853","volume":"6","author":"H Huang","year":"2016","unstructured":"Huang, H. et al. Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B. Sci. Rep. 6, 30853 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"99072_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0022-2275(20)32074-5","volume":"41","author":"MM Sousa","year":"2000","unstructured":"Sousa, M. M., Berglund, L. & Saraiva, M. J. Transthyretin in high density lipoproteins: Association with Apolipoprotein A-I. J. Lipid Res. 41 (1), 58\u201365 (2000).","journal-title":"J. Lipid Res."},{"key":"99072_CR15","doi-asserted-by":"publisher","first-page":"104374","DOI":"10.1016\/j.msard.2022.104374","volume":"69","author":"K Siddiqui","year":"2023","unstructured":"Siddiqui, K. et al. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis. Mult Scler. Relat. Disord. 69, 104374 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"3","key":"99072_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/hep.1840210308","volume":"21","author":"S Takano","year":"1995","unstructured":"Takano, S. et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 21 (3), 650\u2013655 (1995).","journal-title":"Hepatology"},{"issue":"4","key":"99072_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix, J., Reig, M. & Sherman, M. Evidence-Based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150 (4), 835\u2013853 (2016).","journal-title":"Gastroenterology"},{"issue":"9","key":"99072_CR18","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/cncr.21832","volume":"106","author":"S Obi","year":"2006","unstructured":"Obi, S. et al. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106 (9), 1990\u20131997 (2006).","journal-title":"Cancer"},{"key":"99072_CR19","doi-asserted-by":"crossref","unstructured":"Yuan, R. et al. A novel plasma proteomic-based model for predicting liver fibrosis in HIV\/HBV co-infected adults. J Med Virol. ;95(1):e28222. (2023).","DOI":"10.1002\/jmv.28222"},{"key":"99072_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fphar.2015.00265","volume":"6","author":"M Zamanian-Daryoush","year":"2015","unstructured":"Zamanian-Daryoush, M. & DiDonato, J. A. Apolipoprotein A-I and cancer. Front. Pharmacol. 6, 265 (2015).","journal-title":"Front. Pharmacol."},{"issue":"7","key":"99072_CR21","doi-asserted-by":"publisher","first-page":"e68381","DOI":"10.1371\/journal.pone.0068381","volume":"8","author":"HK Fye","year":"2013","unstructured":"Fye, H. K. et al. Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two West African populations. PLoS One. 8 (7), e68381 (2013).","journal-title":"PLoS One"},{"issue":"3","key":"99072_CR22","first-page":"246","volume":"12","author":"HJ Gao","year":"2015","unstructured":"Gao, H. J. et al. Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum. Cancer Biol. Med. 12 (3), 246\u2013254 (2015).","journal-title":"Cancer Biol. Med."},{"key":"99072_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1479-5876-11-239","volume":"11","author":"ST Dillon","year":"2013","unstructured":"Dillon, S. T. et al. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J. Transl Med. 11, 239 (2013).","journal-title":"J. Transl Med."},{"issue":"3","key":"99072_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4254\/wjh.v2.i3.127","volume":"2","author":"M Pleguezuelo","year":"2010","unstructured":"Pleguezuelo, M. et al. Proteomic analysis for developing new biomarkers of hepatocellular carcinoma. World J. Hepatol. 2 (3), 127\u2013135 (2010).","journal-title":"World J. Hepatol."},{"issue":"12","key":"99072_CR25","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1074\/mcp.M113.031252","volume":"12","author":"MG Mustafa","year":"2013","unstructured":"Mustafa, M. G. et al. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients. Mol. Cell. Proteom. 12 (12), 3640\u20133652 (2013).","journal-title":"Mol. Cell. Proteom."},{"key":"99072_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12944-016-0232-5","volume":"15","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. The mechanism of apoliprotein A1 down-regulated by hepatitis B virus. Lipids Health Dis. 15, 64 (2016).","journal-title":"Lipids Health Dis."},{"issue":"29","key":"99072_CR27","doi-asserted-by":"publisher","first-page":"21237","DOI":"10.1074\/jbc.M113.468967","volume":"288","author":"M Zamanian-Daryoush","year":"2013","unstructured":"Zamanian-Daryoush, M. et al. The cardioprotective protein Apolipoprotein A1 promotes potent anti-tumorigenic effects. J. Biol. Chem. 288 (29), 21237\u201321252 (2013).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"99072_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jgr.2014.06.003","volume":"38","author":"MY Kim","year":"2014","unstructured":"Kim, M. Y., Yoo, B. C. & Cho, J. Y. Ginsenoside-Rp1-induced Apolipoprotein A-1 expression in the LoVo human colon cancer cell line. J. Ginseng Res. 38 (4), 251\u2013255 (2014).","journal-title":"J. Ginseng Res."},{"issue":"43","key":"99072_CR29","doi-asserted-by":"publisher","first-page":"70654","DOI":"10.18632\/oncotarget.12203","volume":"7","author":"XL Ma","year":"2016","unstructured":"Ma, X. L. et al. Apolipoprotein A1: A novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget 7 (43), 70654\u201370668 (2016).","journal-title":"Oncotarget"},{"issue":"12","key":"99072_CR30","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1440-1746.2011.06796.x","volume":"26","author":"X Xu","year":"2011","unstructured":"Xu, X. et al. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: Protein disulfide-isomerase A6 and Apolipoprotein A-I. J. Gastroenterol. Hepatol. 26 (12), 1787\u20131794 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"99072_CR31","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.2147\/OTT.S279997","volume":"13","author":"XC Ni","year":"2020","unstructured":"Ni, X. C. et al. Role of lipids and apolipoproteins in predicting the prognosis of hepatocellular carcinoma after resection. Onco Targets Ther. 13, 12867\u201312880 (2020).","journal-title":"Onco Targets Ther."},{"issue":"1","key":"99072_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1186\/s12885-018-5028-8","volume":"18","author":"M Mao","year":"2018","unstructured":"Mao, M. et al. A novel score based on serum Apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC Cancer. 18 (1), 1178 (2018).","journal-title":"BMC Cancer"},{"issue":"4","key":"99072_CR33","first-page":"377","volume":"6","author":"X Wen","year":"2018","unstructured":"Wen, X. et al. Integration of prealbumin into Child\u2013Pugh classification improves prognosis predicting accuracy in HCC patients considering curative surgery. J. Clin. Transl Hepatol. 6 (4), 377\u2013384 (2018).","journal-title":"J. Clin. Transl Hepatol."},{"key":"99072_CR34","doi-asserted-by":"publisher","first-page":"775425","DOI":"10.3389\/fonc.2021.775425","volume":"11","author":"Y Fan","year":"2021","unstructured":"Fan, Y. et al. Preoperative serum prealbumin level and adverse prognosis in patients with hepatocellular carcinoma after hepatectomy: A meta-analysis. Front. Oncol. 11, 775425 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"99072_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mc.22732","volume":"57","author":"P Katare","year":"2018","unstructured":"Katare, P., Malik, D. & Mani, S. J. Novel mutations in transthyretin gene associated with hepatocellular carcinoma. Mol. Carcinog. 57 (1), 70\u201377 (2018).","journal-title":"Mol. Carcinog."},{"issue":"12","key":"99072_CR36","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/ans.14458","volume":"88","author":"T Shimura","year":"2018","unstructured":"Shimura, T. et al. Clinical significance of serum transthyretin level in patients with hepatocellular carcinoma. ANZ J. Surg. 88 (12), 1328\u20131332 (2018).","journal-title":"ANZ J. Surg."},{"issue":"6","key":"99072_CR37","doi-asserted-by":"publisher","first-page":"BSR20192690","DOI":"10.1042\/BSR20192690","volume":"40","author":"RR Huo","year":"2020","unstructured":"Huo, R. R. et al. Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy. Biosci. Rep. 40 (6), BSR20192690 (2020).","journal-title":"Biosci. Rep."},{"key":"99072_CR38","doi-asserted-by":"publisher","first-page":"7831","DOI":"10.2147\/IJGM.S384140","volume":"15","author":"H Huang","year":"2022","unstructured":"Huang, H. et al. Identification of the level of exosomal protein by parallel reaction monitoring technology in HCC patients. Int. J. Gen. Med. 15, 7831\u20137842 (2022).","journal-title":"Int. J. Gen. Med."},{"issue":"9","key":"99072_CR39","doi-asserted-by":"publisher","first-page":"e0138913","DOI":"10.1371\/journal.pone.0138913","volume":"10","author":"FM Awan","year":"2015","unstructured":"Awan, F. M. et al. Identification of Circulating biomarker candidates for hepatocellular carcinoma (HCC): An integrated prioritization approach. PLoS One. 10 (9), e0138913 (2015).","journal-title":"PLoS One"},{"issue":"9","key":"99072_CR40","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1245\/s10434-012-2338-y","volume":"19","author":"H Iwako","year":"2012","unstructured":"Iwako, H. et al. Prognostic significance of antithrombin III levels for outcomes in patients with hepatocellular carcinoma after curative hepatectomy. Ann. Surg. Oncol. 19 (9), 2888\u20132896 (2012).","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"99072_CR41","doi-asserted-by":"publisher","first-page":"101583","DOI":"10.1016\/j.clinre.2020.11.013","volume":"45","author":"X Cao","year":"2021","unstructured":"Cao, X. et al. Combination of serum Paraoxonase\/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients. Clin. Res. Hepatol. Gastroenterol. 45 (5), 101583 (2021).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"3","key":"99072_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3350\/cmh.2020.0032","volume":"26","author":"T Inoue","year":"2020","unstructured":"Inoue, T. & Tanaka, Y. Novel biomarkers for the management of chronic hepatitis B. Clin. Mol. Hepatol. 26 (3), 261\u2013279 (2020).","journal-title":"Clin. Mol. Hepatol."},{"issue":"8","key":"99072_CR43","doi-asserted-by":"publisher","first-page":"e0238251","DOI":"10.1371\/journal.pone.0238251","volume":"15","author":"TT Chang","year":"2020","unstructured":"Chang, T. T. & Ho, C. H. Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma. PLoS One. 15 (8), e0238251 (2020).","journal-title":"PLoS One"},{"issue":"5","key":"99072_CR44","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/S0002-9440(10)63406-2","volume":"165","author":"T Sukata","year":"2004","unstructured":"Sukata, T. et al. alpha(2)-Macroglobulin: A novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. Am. J. Pathol. 165 (5), 1479\u20131488 (2004).","journal-title":"Am. J. Pathol."},{"issue":"11","key":"99072_CR45","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/dna.1996.15.1001","volume":"15","author":"S Tabak","year":"1996","unstructured":"Tabak, S. et al. Transcriptionally active haptoglobin-related (Hpr) gene in hepatoma G2 and leukemia molt-4 cells. DNA Cell. Biol. 15 (11), 1001\u20131007 (1996).","journal-title":"DNA Cell. Biol."},{"key":"99072_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molimm.2018.02.013","volume":"96","author":"L Th\u00f6rnqvist","year":"2018","unstructured":"Th\u00f6rnqvist, L. & Ohlin, M. The functional 3\u2032-end of Immunoglobulin heavy chain variable (IGHV) genes. Mol. Immunol. 96, 61\u201368 (2018).","journal-title":"Mol. Immunol."},{"issue":"9","key":"99072_CR47","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3109\/10428194.2011.582907","volume":"52","author":"K Katsibardi","year":"2011","unstructured":"Katsibardi, K. et al. Clinical significance of productive Immunoglobulin heavy chain gene rearrangements in childhood acute lymphoblastic leukemia. Leuk. Lymphoma. 52 (9), 1751\u20131757 (2011).","journal-title":"Leuk. Lymphoma"},{"issue":"Suppl 1","key":"99072_CR48","first-page":"S83","volume":"78","author":"GE Marti","year":"2010","unstructured":"Marti, G. E. et al. Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies. Cytometry B Clin. Cytom. 78 (Suppl 1), S83\u201390 (2010).","journal-title":"Cytometry B Clin. Cytom"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99072-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:02:38Z","timestamp":1746597758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99072-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99072"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99072-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Zhongnan Hospital of Wuhan University, and all individuals signed an informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"15871"}}